Sunday, June 20, 2010

Leading Cosmetic Surgeon Offers Newly FDA-Approved Sculptra - the "Liquid Facelift"

Leading Cosmetic Surgeon Offers Newly FDA-Approved Sculptra - the "Liquid Facelift"

Westlake Dermatology & Cosmetic Surgery announced today the addition of Sculptra to the procedures it offers. Dr. Gregory Nikolaidis is one of approximately 70 physicians nationwide selected and trained by Aventis Pharmaceuticals in use of this revolutionary new product/procedure. Nikolaidis recently spent three days in Chicago and one week in Germany training with world-renown cosmetic surgeons and representatives from Aventis in the use of what medical professionals and beauty experts are billing as the “liquid facelift.”

Austin, TX (PRWEB) August 27, 2004

Westlake Dermatology & Cosmetic Surgery announced today the addition of Sculptra to the procedures it offers. Dr. Gregory Nikolaidis is one of approximately 70 physicians nationwide selected and trained by Aventis Pharmaceuticals in use of this revolutionary new product/procedure. Nikolaidis recently spent three days in Chicago and one week in Germany training with world-renown cosmetic surgeons and representatives from Aventis in the use of what medical professionals and beauty experts are billing as the “liquid facelift.”

Sculptra works by both filling in lines and wrinkles and by stimulating the body to produce new collagen and underlying tissue, thereby creating a fuller, more youthful appearance.

“This product will transform the field of cosmetic surgery,” said Nikolaidis. “Unlike other fillers, such as Restylane and Cosmoplast, which last only a few months, Sculptra’s effects last up to two years or more.”

Sculptra is marketed under the trade name NEW-FILL® in Europe, where it has been used since 1999 as a wrinkle-filling product. It has been used by an estimated 100,000 people in more than 30 countries throughout Europe and South America to treat facial volume imperfections, including signs of aging, such as wrinkles, folds, dark circles and sunken cheeks.

“Facial lipoatrophy is a condition that results in loss of fat in the cheeks, temples and eye sockets. The sunken cheeks, hollow eyes, indentations and wrinkling may make a person appear exhausted and unhealthy,” said Dr. Sharon Levy, Senior Director of Scientific & Medical Affairs for Dermik Laboratories, the United States arm of Aventis Pharmaceuticals. Sculptra is the first truly effective product/procedure designed to alleviate this condition.

About Westlake Dermatology & Cosmetic Surgery

Westlake Dermatology & Cosmetic Surgery provides state-of-the-art treatment for diseases of the skin, as well as the latest in cosmetic procedures. The practice of cosmetic dermatology continues to be one of the fastest growing medical specialties. Westlake Dermatology & Cosmetic Surgery patients have access to the most current, cutting-edge medical technology and therapies available for beautiful skin at any age. Dr. Nikolaidis specializes in minimally-or-non-invasive cosmetic procedures. He is the leading provider of ThermaLift in Texas and his practice was recently recognized as a national Botox training center. Visit www. westlakedermatology. com for more information.